Paul A Friedman, director of Incyte Corp, the US-based company operating in the pharmaceuticals and healthcare sector, has sold 720,036 shares, representing a 0.4469% stake in the company. The shares were sold at a price of $65.82 each for gross proceeds of $47.39m.
Full Name: Paul A Friedman
DOB: 1943
Gender: Male
Citizenship: American
Languages: English
Liquidity Event: The shares were sold on February 18 2014 at a price of $65.82 each, for gross proceeds of $47.39m.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Profile:
Paul A Friedman, born in 1943, is president and chief executive officer of Incyte Corporation. He is also the director of Auxilium Pharmaceuticals, Inc. and a non-executive director of Gliknik Inc. He served as president of R&D for the DuPont Merck Pharmaceutical Company and as senior vice-president at Merck Research Laboratories. He was also director of Bausch & Lomb Incorporated and Sirtris Pharmaceuticals, Inc.
